Predictive Oncology (POAI)
(Delayed Data from NSDQ)
$1.63 USD
-0.13 (-7.39%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.62 -0.01 (-0.61%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
POAI 1.63 -0.13(-7.39%)
Will POAI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for POAI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for POAI
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) Reports Q1 Loss, Lags Revenue Estimates
POAI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for POAI
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
The 3 Most Undervalued AI Penny Stocks to Buy in May 2024
AI-Fueled Penny Stocks: 3 High-Risk, High-Reward Opportunities
GME, ONVO and POAI among pre-market losers
12 Health Care Stocks Moving In Monday's Pre-Market Session